These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ASHP guidelines on compounding sterile preparations. American Society of Health System Pharmacists Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608 [No Abstract] [Full Text] [Related]
4. ASHP statement on hospital drug control systems. Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439 [No Abstract] [Full Text] [Related]
5. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471 [TBL] [Abstract][Full Text] [Related]
6. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
7. Production of sterile fluids in hospital pharmacies. Gillett AP J Hosp Infect; 1981 Jun; 2(2):113-5. PubMed ID: 6174572 [No Abstract] [Full Text] [Related]
8. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy. Patel JA; Curtis EG; Phillips GL Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003 [No Abstract] [Full Text] [Related]
9. ASHP gears up multistep action plan regarding sterile drug products. Am J Hosp Pharm; 1991 Mar; 48(3):386, 389-90. PubMed ID: 2028985 [No Abstract] [Full Text] [Related]
10. Color-coding process for monitoring medication beyond-use dates. Hattoy S; Kozakiewicz J; Seo T Am J Health Syst Pharm; 2010 Oct; 67(19):1591. PubMed ID: 20852157 [No Abstract] [Full Text] [Related]
11. Needed: serious attention to sterile products. Myers CE Am J Health Syst Pharm; 1996 Nov; 53(21):2582. PubMed ID: 8913386 [No Abstract] [Full Text] [Related]
12. Preparing for automated dispensing devices. Magnus GH Am J Health Syst Pharm; 1995 Nov; 52(21):2406-8. PubMed ID: 8564603 [No Abstract] [Full Text] [Related]
13. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products. Sprake JM Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209 [No Abstract] [Full Text] [Related]
14. [Introduction of a traceability system in the pharmacy oncology area in a tertiary hospital]. Cañamares-Orbis I; Cortijo-Cascajares S; García-Muñoz C; Goyache-Goñi MP; Ferrari-Piquero JM Rev Calid Asist; 2014; 29(1):58-9. PubMed ID: 24440579 [No Abstract] [Full Text] [Related]
15. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality. Stucki C; Sautter AM; Favet J; Bonnabry P Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087 [TBL] [Abstract][Full Text] [Related]
16. QUALITY CONTROL PROCEDURES FOR THE HOSPITAL PHARMACY. SKOLAUT MW Hospitals; 1964 May; 38():83-90. PubMed ID: 14144697 [No Abstract] [Full Text] [Related]
17. A pharmacy-based quality assurance program. Meisel S QRB Qual Rev Bull; 1983 May; 9(5):147-8. PubMed ID: 6408561 [No Abstract] [Full Text] [Related]
18. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
19. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding. Akers MJ Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676 [TBL] [Abstract][Full Text] [Related]
20. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]